New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 28, 2014
07:47 EDTMYGN, LHMyriad Genetics participation pacts to be terminated by NJ Horizon Blue Cross
Horizon Blue Cross Blue Shield of New Jersey, an independent licensee of the Blue Cross and Blue Shield Association, announced yesterday that it is terminating its participation agreements with Myriad Genetics (MYGN), effective June 15 for patients enrolled in Horizon BCBSNJ managed care plans and effective July 3 for patients enrolled in Horizon BCBSNJ PPO and Indemnity plans. Following the terminations of Myriad Genetics, LabCorp (LH) will be the only participating clinical laboratory to provide BRCA-specific genetic testing for Horizon BCBSNJ patients, the insurer noted. Reference Link
News For MYGN;LH From The Last 14 Days
Check below for free stories on MYGN;LH the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 29, 2014
07:45 EDTMYGNMyriad Genetics presents tumor BRACAnalysis CDx study at ESMO
Subscribe for More Information
07:24 EDTMYGNStephens to hold an investor trip
Subscribe for More Information
06:45 EDTLHLabCorp removed from short-term buy list at Deutsche Bank
Subscribe for More Information
September 26, 2014
10:09 EDTLHHigh option volume stocks
Subscribe for More Information
September 25, 2014
09:13 EDTLHOn The Fly: Pre-market Movers
HIGHER: LipoScience (LPDX), up 63% after agreeing to be acquired by LabCorp (LH) for $5.25 per share in cash... Magnum Hunter (MHR), up 12.5% after announcing that throughput volumes on Eureka Hunter's gas gathering pipeline system have increased to about 316,500 MMBtu per day... Jabil Circuit (JBL), up 4.7% following its report of better than expected fourth EPS and revenue... JD.com (JD), up 0.7% after the stock was initiated with an Outperform rating at Macquarie. LOWER: Yahoo (YHOO), down 0.6% after RBC Capital downgraded its rating on the stock to Sector Perform from Outperform, saying the risk/reward is less attractive following Alibaba's (BABA) initial public offering... HB Fuller (FUL), down 15% after reporting quarterly results and guidance that missed analyst estimates... Omnova Solutions (OMN), down 10.8% after its Q3 adjusted EPS missed expectations... Pacira Pharmaceuticals (PCRX), down 9.2% after receiving an FDA warning letter over certain promotional materials on Exparel.
07:02 EDTLHLabCorp acquires LipoScience
LabCorp (LH) and LipoScience (LPDX) announced that they entered into a definitive merger agreement under which LabCorp would acquire LipoScience for a purchase price of $5.25 per share in cash, or a transaction value of $85.3M which represents a total enterprise value of approximately $63M. The Board of Directors of LipoScience has unanimously approved the agreement and recommended approval of the transaction by LipoScience’s stockholders. The transaction is subject to customary closing conditions including the expiration or early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and approval by LipoScience’s stockholders. The transaction is expected to close in Q4.
07:00 EDTLHLabCorp acquires LipoScience for $5.25 per share in cash
06:58 EDTLHLabCorp agrees to acquire LipoScience for $5.25 per share
Subscribe for More Information
06:56 EDTLHLabCorp to acquire LipoScience for $5.25 per share in all cash transaction
06:56 EDTLHLabCorp agrees to acquire LipoScience for $5.25 per share
Subscribe for More Information
September 16, 2014
08:04 EDTLHLabCorp, ARCA Biopharma present GENETIC-AF poster at HFSoA meeting
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use